SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Tarsus Pharmaceuticals Posts Q3 Loss of $14.40

Tarsus Pharmaceuticals reported a Q3 loss of $14.40, versus a FactSet estimate of a $1.46 loss.

TARS

Related stories